BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38134062)

  • 61. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
    El-Serag HB; Davila JA
    Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Validation of the Toronto hepatocellular carcinoma risk index for patients with cirrhosis in China: a retrospective cohort study.
    Zhang H; Zhu J; Xi L; Xu C; Wu A
    World J Surg Oncol; 2019 Apr; 17(1):75. PubMed ID: 31039803
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of the Effect of Cumulative Operator Experience on Hepatocellular Carcinoma Recurrence after Primary Treatment with Radiofrequency Ablation.
    Lee TY; Lin JT; Ho HJ; Wu MS; Wu CY
    Radiology; 2015 Jul; 276(1):294-301. PubMed ID: 25763830
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy.
    Hosokawa T; Kurosaki M; Tsuchiya K; Matsuda S; Muraoka M; Suzuki Y; Tamaki N; Yasui Y; Nakata T; Nishimura T; Suzuki S; Ueda K; Nakanishi H; Itakura J; Takahashi Y; Izumi N
    World J Gastroenterol; 2013 Jan; 19(2):249-57. PubMed ID: 23345948
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The survival strength of younger patients in BCLC stage 0-B of hepatocellular carcinoma: basing on competing risk model.
    Yan H; Wang X; Liu X; Wang P; Yu L; Zhou D; Yang Z
    BMC Cancer; 2022 Feb; 22(1):185. PubMed ID: 35180841
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
    Ding J; Wen Z
    BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
    Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
    J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor.
    Garancini M; Goffredo P; Pagni F; Romano F; Roman S; Sosa JA; Giardini V
    Liver Transpl; 2014 Aug; 20(8):952-9. PubMed ID: 24777610
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cardiovascular-Specific Mortality among Gastrointestinal Stromal Tumor Patients: A Population-Based Analysis.
    Yao H; Shi H; Fan M; Yuan L; Lin R
    Oxid Med Cell Longev; 2023; 2023():3619306. PubMed ID: 36825080
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts.
    Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Waterworth DM; Kendrick S; Sattar N; Alazawi W
    BMC Med; 2019 May; 17(1):95. PubMed ID: 31104631
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.
    Lai SW; Chen PC; Liao KF; Muo CH; Lin CC; Sung FC
    Am J Gastroenterol; 2012 Jan; 107(1):46-52. PubMed ID: 22085817
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
    Ioannou GN; Green P; Kerr KF; Berry K
    J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community.
    Chang KC; Tsai PS; Hsu MC; Hung SF; Tsai CC; Lu SN
    J Gastroenterol; 2010 Jun; 45(6):636-45. PubMed ID: 20054698
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatic and extrahepatic malignancies in primary biliary cirrhosis.
    Floreani A; Baragiotta A; Baldo V; Menegon T; Farinati F; Naccarato R
    Hepatology; 1999 May; 29(5):1425-8. PubMed ID: 10216125
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients.
    Wang HM; Hung CH; Lu SN; Chen CH; Lee CM; Hu TH; Wang JH
    Liver Int; 2013 May; 33(5):756-61. PubMed ID: 23405889
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hypovascular tumors developed into hepatocellular carcinoma at a high rate despite the elimination of hepatitis C virus by direct-acting antivirals.
    Tabu K; Mawatari S; Oda K; Kumagai K; Inada Y; Uto H; Saisyoji A; Hiramine Y; Hashiguchi M; Tamai T; Hori T; Fujisaki K; Imanaka D; Kure T; Taniyama O; Toyodome A; Ijuin S; Sakae H; Sakurai K; Moriuchi A; Kanmura S; Ido A
    PLoS One; 2020; 15(8):e0237475. PubMed ID: 32790728
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Time-trends in incidence and prognosis of hepatocellular carcinoma in Denmark: A nationwide register-based cohort study.
    Jepsen P; Andersen MW; Villadsen GE; Ott P; Vilstrup H
    Liver Int; 2017 Jun; 37(6):871-878. PubMed ID: 27943604
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prediction of hepatocellular carcinoma development by aminotransferase to platelet ratio index in primary biliary cholangitis.
    Cheung KS; Seto WK; Fung J; Mak LY; Lai CL; Yuen MF
    World J Gastroenterol; 2017 Nov; 23(44):7863-7874. PubMed ID: 29209127
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.
    Hsu YC; Yip TC; Ho HJ; Wong VW; Huang YT; El-Serag HB; Lee TY; Wu MS; Lin JT; Wong GL; Wu CY
    J Hepatol; 2018 Aug; 69(2):278-285. PubMed ID: 29551708
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B.
    Shin H; Jung YW; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Kim YY; Choi JY; Kim SU
    Clin Mol Hepatol; 2019 Dec; 25(4):390-399. PubMed ID: 31146508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.